SNHG1 and esophageal squamous cell carcinoma: Furthermore, Kaplan-Meier analysis revealed that ESCC patients with elevated levels of SNHG1 generally experienced poorer overall survival compared to those with lower levels of SNHG1 (Fig. 1B), suggesting the potential of SNHG1 as a prognostic biomarker for ESCC.